Lifecore Biomedical Inc. (LFCR)
Lifecore Biomedical Statistics
Share Statistics
Lifecore Biomedical has 37.03M shares outstanding. The number of shares has increased by 21.21% in one year.
| Shares Outstanding | 37.03M |
| Shares Change (YoY) | 21.21% |
| Shares Change (QoQ) | 0.54% |
| Owned by Institutions (%) | 72.23% |
| Shares Floating | 32.86M |
| Failed to Deliver (FTD) Shares | 64 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 2.6M, so 7.03% of the outstanding shares have been sold short.
| Short Interest | 2.6M |
| Short % of Shares Out | 7.03% |
| Short % of Float | 11.39% |
| Short Ratio (days to cover) | 10.09 |
Valuation Ratios
The PE ratio is 14.26 and the forward PE ratio is -10.02. Lifecore Biomedical's PEG ratio is -0.13.
| PE Ratio | 14.26 |
| Forward PE | -10.02 |
| PS Ratio | 1.34 |
| Forward PS | 1.5 |
| PB Ratio | 3.18 |
| P/FCF Ratio | -9.44 |
| PEG Ratio | -0.13 |
Enterprise Valuation
Lifecore Biomedical has an Enterprise Value (EV) of 293.16M.
| EV / Sales | 2.29 |
| EV / EBITDA | 8.23 |
| EV / EBIT | -1350.98 |
| EV / FCF | -16.16 |
Financial Position
The company has a current ratio of 2.08, with a Debt / Equity ratio of 2.42.
| Current Ratio | 2.08 |
| Quick Ratio | 1.06 |
| Debt / Equity | 2.42 |
| Debt / EBITDA | 3.66 |
| Debt / FCF | -7.19 |
| Interest Coverage | 0.52 |
Financial Efficiency
Return on Equity is 22.29% and Return on Invested Capital is 4.16%.
| Return on Equity | 22.29% |
| Return on Assets | 4.39% |
| Return on Invested Capital | 4.16% |
| Revenue Per Employee | $244.77K |
| Profits Per Employee | $22.93K |
| Employee Count | 524 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.16 |
Taxes
| Income Tax | 183K |
| Effective Tax Rate | 1.92% |
Stock Price Statistics
The stock price has increased by 1.42% in the last 52 weeks. The beta is 0.8, so Lifecore Biomedical's price volatility has been higher than the market average.
| Beta | 0.8 |
| 52-Week Price Change | 1.42% |
| 50-Day Moving Average | 6.16 |
| 200-Day Moving Average | 5.95 |
| Relative Strength Index (RSI) | 52.86 |
| Average Volume (20 Days) | 217.68K |
Income Statement
In the last 12 months, Lifecore Biomedical had revenue of 128.26M and earned 12.01M in profits. Earnings per share was 0.39.
| Revenue | 128.26M |
| Gross Profit | 41.85M |
| Operating Income | 9.33M |
| Net Income | 12.01M |
| EBITDA | 35.6M |
| EBIT | 27.6M |
| Earnings Per Share (EPS) | 0.39 |
Balance Sheet
The company has 8.46M in cash and 130.36M in debt, giving a net cash position of -121.9M.
| Cash & Cash Equivalents | 8.46M |
| Total Debt | 130.36M |
| Net Cash | -121.9M |
| Retained Earnings | -166.52M |
| Total Assets | 237.69M |
| Working Capital | 53.09M |
Cash Flow
In the last 12 months, operating cash flow was -217K and capital expenditures -17.92M, giving a free cash flow of -18.14M.
| Operating Cash Flow | -217K |
| Capital Expenditures | -17.92M |
| Free Cash Flow | -18.14M |
| FCF Per Share | -0.6 |
Margins
Gross margin is 32.63%, with operating and profit margins of 7.28% and 9.37%.
| Gross Margin | 32.63% |
| Operating Margin | 7.28% |
| Pretax Margin | 7.42% |
| Profit Margin | 9.37% |
| EBITDA Margin | 27.76% |
| EBIT Margin | 7.28% |
| FCF Margin | -14.14% |
Dividends & Yields
LFCR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 7.01% |
| FCF Yield | -10.59% |
Analyst Forecast
The average price target for LFCR is $8, which is 24.8% higher than the current price. The consensus rating is "Hold".
| Price Target | $8 |
| Price Target Difference | 24.8% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Scores
| Altman Z-Score | -0.14 |
| Piotroski F-Score | 5 |